As of 2026-05-16, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (40,805.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -34816831.3%.
The range of the Relative Valuation is (37,173.33) - (42,001.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 21.1x | 18.9x |
| Forward P/E multiples | 16.6x - 19.7x | 19.3x |
| Fair Price | (37,173.33) - (42,001.59) | (40,805.21) |
| Upside | -31717960.0% - -35837636.0% | -34816831.3% |
| Date | P/E |
| 2026-05-14 | -0.00 |
| 2026-05-13 | -0.00 |
| 2026-05-12 | -0.00 |
| 2026-05-11 | -0.00 |
| 2026-05-08 | -0.00 |
| 2026-05-07 | -0.00 |
| 2026-05-06 | -0.00 |
| 2026-05-05 | -0.00 |
| 2026-05-04 | -0.00 |
| 2026-05-01 | -0.00 |
| 2026-04-30 | -0.00 |
| 2026-04-29 | -0.00 |
| 2026-04-28 | -0.00 |
| 2026-04-27 | -0.00 |
| 2026-04-24 | -0.00 |
| 2026-04-23 | -0.00 |
| 2026-04-22 | -0.00 |
| 2026-04-21 | -0.00 |
| 2026-04-20 | -0.00 |
| 2026-04-17 | -0.00 |
| 2026-04-16 | -0.00 |
| 2026-04-15 | -0.00 |
| 2026-04-14 | -0.00 |
| 2026-04-13 | -0.00 |
| 2026-04-10 | -0.00 |
| 2026-04-09 | -0.00 |
| 2026-04-08 | -0.00 |
| 2026-04-07 | -0.00 |
| 2026-04-06 | -0.00 |
| 2026-04-02 | -0.00 |
| 2026-04-01 | -0.00 |
| 2026-03-31 | -0.00 |
| 2026-03-30 | -0.00 |
| 2026-03-27 | -0.00 |
| 2026-03-26 | -0.00 |
| 2026-03-25 | -0.00 |
| 2026-03-24 | -0.00 |
| 2026-03-23 | -0.00 |
| 2026-03-20 | -0.00 |
| 2026-03-19 | -0.00 |
| 2026-03-18 | -0.00 |
| 2026-03-17 | -0.00 |
| 2026-03-16 | -0.00 |
| 2026-03-13 | -0.00 |
| 2026-03-12 | -0.00 |
| 2026-03-11 | -0.00 |
| 2026-03-10 | -0.00 |
| 2026-03-09 | -0.00 |
| 2026-03-06 | -0.00 |
| 2026-03-05 | -0.00 |